Dr. Gedallovich is a current Transplant Hepatology Fellow at Stanford University. Prior to this, she completed Gastroenterology fellowship at Stanford University and Hospice & Palliative Medicine fellowship at the University of California San Francisco.
Dr. Amar Bansal is a nephrologist and palliative care physician at the University of Pittsburgh. He is the Associate Program Director for the nephrology training program. He has an interest in AKI-HRS and serious illness communication. He is the course director for "GiTalk," a communication workshop based on VitalTalk designed for GI providers. It is held annually for GI fellows and APP's at UPMC.
Christopher Woodrell is a board-certified internist and hospice and palliative medicine physician. He is a clinical research scientist with an appointment as Associate Professor at the Icahn School of Medicine at Mount Sinai and Staff Physician at the James J. Peters VA Medical Center in the Bronx. His research interests include developing and testing palliative and supportive interventions to improve the quality of life of people living with cancer and their families, and particularly those with hepatocellular carcinoma.
Dr. Marina Bárcena-Varela is a researcher at the Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM) in Madrid, Spain, where she holds a competitive national grant, Atracción de Talento–César Nombela, awarded by the Comunidad de Madrid. She is a former postdoctoral researcher in the Department of Oncological Sciences at the Icahn School of Medicine at Mount Sinai, New York.
Prof. Dr. Mathias Heikenwälder is a trained molecular biologist, with expertise in immunology and a strong link to translational research evoked by 10 years of work and expertise in a Pathology Institution (Clinical Pathology, University Hospital Zurich). Since October 2015 he is Department head at the German Cancer Research Center (DKFZ) in Heidelberg focusing on the link between chronic inflammation and cancer. Since October 2022 he is director of the M3 Research Center, University Tübingen. Prof.
Dr David J. Pinato is a Clinician Scientist and Consultant Medical Oncologist working within the Department of Surgery and Cancer at Imperial College in London. <br><br>He is Director of Developmental Cancer Therapeutics at Imperial College, where he leads a translational research program focusing on the early clinical implementation of novel experimental anticancer therapies to the clinic, with particular emphasis on anti-cancer immunotherapy.
Dr. Schnabl is a trained gastroenterologist and physician-scientist. He is Professor of Medicine in the Department of Medicine at the University of California San Diego, founding Director of the NIH-supported San Diego Digestive Diseases Research Center (SDDRC) and Director of Research for the Division of Gastroenterology. His research focus is to understand the complex multi-directional interactions that occur between the gut microbiota and the liver.
Dr. Akiyama is an Associate Professor of Medicine and Clinician-Investigator at Albert Einstein College of Medicine and Montefiore Medical Center. In addition to providing care and treatment to people living with HIV, HCV, and substance use disorders, Dr. Akiyama conducts research focusing on models of care for HCV, HIV, and other infectious diseases in resource limited settings, with a particular focus on the criminal legal system. Dr.
Dr. Natasha Martin is an infectious disease economic modeler who develops dynamic transmission models to evaluate the impact and cost-effectiveness of public health interventions. She is currently a Professor in the Division of Infectious Diseases and Global Public Health at the University of California San Diego and holds an honorary professor position at the University of Bristol. She is the vice president of the International Network of Hepatitis and Health in Substance Users (INHSU).
Catherine Chappell is an Assistant Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh. She is board certified in Obstetrics and Gynecology, Addiction Medicine and Complex Family Planning. Her research focuses on the evaluation of direct-acting antivirals for HCV in pregnancy.